Physician profile
Jonathan S Cooper
NPI 1497723522
$9,330.41
in general payments reported to CMS, 2019-2025
59 companies · $1,013 in 2025
The $1,013 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,145 · 2020: $1,355 · 2021: $2,682 · 2022: $276 · 2023: $872 · 2024: $987 · 2025: $1,013.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,872.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,871.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,109.92 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Glaxosmithkline, LLC. | $1,005.12 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $909.51 | 2019-2025 | Evenity, Prolia, Otezla |
| Astrazeneca Pharmaceuticals LP | $537.35 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $531.84 | 2021-2025 | Ubrelvy, Vraylar |
| Lilly USA, LLC | $512.98 | 2019-2024 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $329.64 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $314.51 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $307.75 | 2019-2023 | Xarelto |
| Allergan, INC. | $297.91 | 2019-2020 | |
| Medtronic Minimed, INC. | $284.20 | 2019 | |
| Merck Sharp & Dohme LLC | $279.22 | 2019-2024 | Vaxelis, Gardasil 9, Vaxneuvance |
| Amarin Pharma, INC. | $188.44 | 2020-2021 | |
| Medtronic, INC. | $171.80 | 2021-2023 | Minimed 770g, Guardian Connect, Activos 10 Bone Cement |
| Lundbeck LLC | $171.73 | 2020-2025 | Rexulti |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.